ArticleFrontiers in oncology2022

Targeting Mcl-1 by AMG-176 During Ibrutinib and Venetoclax Therapy in Chronic Lymphocytic Leukemia.

Xue Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.